坐骨神経痛治療の世界市場2023~2027

■ 英語タイトル:Global Sciatica Treatment Market 2023-2027

調査会社Technavio社が発行したリサーチレポート(データ管理コード:IRTNTR73640-23)■ 発行会社/調査会社:Technavio
■ 商品コード:IRTNTR73640-23
■ 発行日:2023年8月24日
■ 調査対象地域:北米、ヨーロッパ、アジア、その他地域
■ 産業分野:医療
■ ページ数:約120
■ レポート言語:英語
■ レポート形式:PDF
■ 納品方式:Eメール(受注後24時間以内)
■ 販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥380,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥608,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能)
Technavio社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[坐骨神経痛治療の世界市場2023~2027]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

世界の坐骨神経痛治療市場 2023-2027
坐骨神経痛治療市場は、2022年から2027年の間に3,089.08百万米ドル成長し、予測期間中に4.83%のCAGRで加速すると予測されています。
坐骨神経痛治療市場に関するレポートは、全体的な分析、市場規模と予測、傾向、成長ドライバー、課題、および約25のベンダーをカバーするベンダー分析を提供します。

このレポートは、現在の市場シナリオ、最新の傾向と推進力、および全体的な市場環境に関する最新の分析を提供します。 市場は、坐骨神経痛に対する意識の高まり、坐骨神経痛の危険因子の有病率の増加、パイプライン医薬品に対する規制の支援によって牽引されています。

Technavioの坐骨神経痛治療市場は以下のように分類されます:

エンドユーザー別:
- 病院
- クリニック
- その他

製品別:
- 非外科的治療
- 外科的治療

地域別:
- 北米
- ヨーロッパ
- アジア
- その他の世界 (ROW)

この研究は、クロニジンマイクロペレット硬膜外注射の開発が、今後数年間の坐骨神経痛治療市場の成長を促進する主な理由の1つであることを特定しています。 また、坐骨神経痛の研究資金の増加と坐骨神経痛治療のための理学療法への意識の高まりは、市場での大きな需要につながるでしょう。

坐骨神経痛治療市場に関するレポートは、次の分野をカバーしています:
- 坐骨神経痛治療市場規模
- 坐骨神経痛治療市場予測
- 坐骨神経痛治療市場の産業分析

堅牢なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されており、これに沿って、このレポートでは、Amneal Pharmaceuticals Inc., Apotex Inc., Aurobindo Pharma Ltd., Bayer AG, Dr Reddys Laboratories Ltd., Elam Pharma Pvt. Ltd., Fresenius SE and Co. KGaA, Glenmark Pharmaceuticals Ltd., Hikma Pharmaceuticals Plc, Johnson and Johnson, KOLON LIFE SCIENCE, Lupin Ltd., Novartis AG, Omega Laser Systems Ltd., Ozone Pharmaceuticals Ltd., Pfizer Inc., Sanofi, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Viatris Incを含むいくつかの主要な坐骨神経痛治療市場ベンダーの詳細な分析を提供します。また、坐骨神経痛治療市場分析レポートには、市場の成長に影響を与える今後の傾向と課題に関する情報が含まれています。 これは、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。

本調査は、産業の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。
当レポートでは、主要ベンダーの分析に加え、包括的な市場とベンダーの状況を掲載しています。

Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、総括する方法で、市場の詳細な姿を提示しています。また、主要な産業インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査報告書は、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

1.エグゼクティブサマリー
2.市場状況
3.市場規模
4.過去の市場規模
5.ファイブフォース分析
6.坐骨神経痛治療市場のセグメンテーション:エンドユーザー別
7.坐骨神経痛治療市場のセグメンテーション:製品別
8.顧客状況
9.地理的状況
10.推進要因・課題・傾向
11.企業状況
12.企業分析
13.付録

世界の市場調査レポート販売サイト(H&Iグローバルリサーチ株式会社運営)
*** レポート目次(コンテンツ)***

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by End-user
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Product
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global Sciatica Treatment Market 2023-2027 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on global sciatica treatment market 2023-2027 2017 – 2021 ($ billion)
o 4.2 End-user Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – End-user Segment 2017 – 2021 ($ billion)
o 4.3 Product Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – Product Segment 2017 – 2021 ($ billion)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ billion)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ billion)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
• 6 Market Segmentation by End-user
o 6.1 Market segments
o Exhibit 30: Chart on End-user – Market share 2022-2027 (%)
o Exhibit 31: Data Table on End-user – Market share 2022-2027 (%)
o 6.2 Comparison by End-user
o Exhibit 32: Chart on Comparison by End-user
o Exhibit 33: Data Table on Comparison by End-user
o 6.3 Hospital – Market size and forecast 2022-2027
o Exhibit 34: Chart on Hospital – Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Hospital – Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Hospital – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Hospital – Year-over-year growth 2022-2027 (%)
o 6.4 Clinics – Market size and forecast 2022-2027
o Exhibit 38: Chart on Clinics – Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Clinics – Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Clinics – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Clinics – Year-over-year growth 2022-2027 (%)
o 6.5 Others – Market size and forecast 2022-2027
o Exhibit 42: Chart on Others – Market size and forecast 2022-2027 ($ million)
o Exhibit 43: Data Table on Others – Market size and forecast 2022-2027 ($ million)
o Exhibit 44: Chart on Others – Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Others – Year-over-year growth 2022-2027 (%)
o 6.6 Market opportunity by End-user
o Exhibit 46: Market opportunity by End-user ($ million)
o Exhibit 47: Data Table on Market opportunity by End-user ($ million)
• 7 Market Segmentation by Product
o 7.1 Market segments
o Exhibit 48: Chart on Product – Market share 2022-2027 (%)
o Exhibit 49: Data Table on Product – Market share 2022-2027 (%)
o 7.2 Comparison by Product
o Exhibit 50: Chart on Comparison by Product
o Exhibit 51: Data Table on Comparison by Product
o 7.3 Non-surgical treatment – Market size and forecast 2022-2027
o Exhibit 52: Chart on Non-surgical treatment – Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Data Table on Non-surgical treatment – Market size and forecast 2022-2027 ($ million)
o Exhibit 54: Chart on Non-surgical treatment – Year-over-year growth 2022-2027 (%)
o Exhibit 55: Data Table on Non-surgical treatment – Year-over-year growth 2022-2027 (%)
o 7.4 Surgical treatment – Market size and forecast 2022-2027
o Exhibit 56: Chart on Surgical treatment – Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Data Table on Surgical treatment – Market size and forecast 2022-2027 ($ million)
o Exhibit 58: Chart on Surgical treatment – Year-over-year growth 2022-2027 (%)
o Exhibit 59: Data Table on Surgical treatment – Year-over-year growth 2022-2027 (%)
o 7.5 Market opportunity by Product
o Exhibit 60: Market opportunity by Product ($ million)
o Exhibit 61: Data Table on Market opportunity by Product ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 63: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 65: Chart on Geographic comparison
o Exhibit 66: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 67: Chart on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 68: Data Table on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 69: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 70: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 Europe – Market size and forecast 2022-2027
o Exhibit 71: Chart on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 72: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 73: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 74: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.5 Asia – Market size and forecast 2022-2027
o Exhibit 75: Chart on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 76: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 77: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 79: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 83: Chart on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 Canada – Market size and forecast 2022-2027
o Exhibit 87: Chart on Canada – Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on Canada – Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on Canada – Year-over-year growth 2022-2027 (%)
o 9.9 UK – Market size and forecast 2022-2027
o Exhibit 91: Chart on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on UK – Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on UK – Year-over-year growth 2022-2027 (%)
o 9.10 Germany – Market size and forecast 2022-2027
o Exhibit 95: Chart on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.11 China – Market size and forecast 2022-2027
o Exhibit 99: Chart on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 100: Data Table on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 101: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on China – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 103: Market opportunity By Geographical Landscape ($ million)
o Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 105: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 107: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 108: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 109: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 110: Matrix on vendor position and classification
o 12.3 Apotex Inc.
o Exhibit 111: Apotex Inc. – Overview
o Exhibit 112: Apotex Inc. – Product / Service
o Exhibit 113: Apotex Inc. – Key offerings
o 12.4 Aurobindo Pharma Ltd.
o Exhibit 114: Aurobindo Pharma Ltd. – Overview
o Exhibit 115: Aurobindo Pharma Ltd. – Product / Service
o Exhibit 116: Aurobindo Pharma Ltd. – Key offerings
o 12.5 Bayer AG
o Exhibit 117: Bayer AG – Overview
o Exhibit 118: Bayer AG – Business segments
o Exhibit 119: Bayer AG – Key news
o Exhibit 120: Bayer AG – Key offerings
o Exhibit 121: Bayer AG – Segment focus
o 12.6 Dr Reddys Laboratories Ltd.
o Exhibit 122: Dr Reddys Laboratories Ltd. – Overview
o Exhibit 123: Dr Reddys Laboratories Ltd. – Business segments
o Exhibit 124: Dr Reddys Laboratories Ltd. – Key offerings
o Exhibit 125: Dr Reddys Laboratories Ltd. – Segment focus
o 12.7 Elam Pharma Pvt. Ltd.
o Exhibit 126: Elam Pharma Pvt. Ltd. – Overview
o Exhibit 127: Elam Pharma Pvt. Ltd. – Product / Service
o Exhibit 128: Elam Pharma Pvt. Ltd. – Key offerings
o 12.8 Fresenius SE and Co. KGaA
o Exhibit 129: Fresenius SE and Co. KGaA – Overview
o Exhibit 130: Fresenius SE and Co. KGaA – Business segments
o Exhibit 131: Fresenius SE and Co. KGaA – Key news
o Exhibit 132: Fresenius SE and Co. KGaA – Key offerings
o Exhibit 133: Fresenius SE and Co. KGaA – Segment focus
o 12.9 Glenmark Pharmaceuticals Ltd.
o Exhibit 134: Glenmark Pharmaceuticals Ltd. – Overview
o Exhibit 135: Glenmark Pharmaceuticals Ltd. – Product / Service
o Exhibit 136: Glenmark Pharmaceuticals Ltd. – Key offerings
o 12.10 Hikma Pharmaceuticals Plc
o Exhibit 137: Hikma Pharmaceuticals Plc – Overview
o Exhibit 138: Hikma Pharmaceuticals Plc – Business segments
o Exhibit 139: Hikma Pharmaceuticals Plc – Key offerings
o Exhibit 140: Hikma Pharmaceuticals Plc – Segment focus
o 12.11 Johnson and Johnson
o Exhibit 141: Johnson and Johnson – Overview
o Exhibit 142: Johnson and Johnson – Business segments
o Exhibit 143: Johnson and Johnson – Key news
o Exhibit 144: Johnson and Johnson – Key offerings
o Exhibit 145: Johnson and Johnson – Segment focus
o 12.12 Novartis AG
o Exhibit 146: Novartis AG – Overview
o Exhibit 147: Novartis AG – Business segments
o Exhibit 148: Novartis AG – Key offerings
o Exhibit 149: Novartis AG – Segment focus
o 12.13 Omega Laser Systems Ltd.
o Exhibit 150: Omega Laser Systems Ltd. – Overview
o Exhibit 151: Omega Laser Systems Ltd. – Product / Service
o Exhibit 152: Omega Laser Systems Ltd. – Key offerings
o 12.14 Ozone Pharmaceuticals Ltd.
o Exhibit 153: Ozone Pharmaceuticals Ltd. – Overview
o Exhibit 154: Ozone Pharmaceuticals Ltd. – Key offerings
o 12.15 Pfizer Inc.
o Exhibit 155: Pfizer Inc. – Overview
o Exhibit 156: Pfizer Inc. – Product / Service
o Exhibit 157: Pfizer Inc. – Key news
o Exhibit 158: Pfizer Inc. – Key offerings
o 12.16 Teva Pharmaceutical Industries Ltd.
o Exhibit 159: Teva Pharmaceutical Industries Ltd. – Overview
o Exhibit 160: Teva Pharmaceutical Industries Ltd. – Business segments
o Exhibit 161: Teva Pharmaceutical Industries Ltd. – Key news
o Exhibit 162: Teva Pharmaceutical Industries Ltd. – Key offerings
o Exhibit 163: Teva Pharmaceutical Industries Ltd. – Segment focus
o 12.17 Viatris Inc.
o Exhibit 164: Viatris Inc. – Overview
o Exhibit 165: Viatris Inc. – Business segments
o Exhibit 166: Viatris Inc. – Key news
o Exhibit 167: Viatris Inc. – Key offerings
o Exhibit 168: Viatris Inc. – Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 169: Inclusions checklist
o Exhibit 170: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 171: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 172: Research methodology
o Exhibit 173: Validation techniques employed for market sizing
o Exhibit 174: Information sources
o 13.5 List of abbreviations
o Exhibit 175: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by End-user
Exhibits6: Executive Summary – Chart on Market Segmentation by Product
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on global sciatica treatment market 2023-2027 2017 – 2021 ($ billion)
Exhibits19: Historic Market Size – End-user Segment 2017 – 2021 ($ billion)
Exhibits20: Historic Market Size – Product Segment 2017 – 2021 ($ billion)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ billion)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ billion)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on End-user – Market share 2022-2027 (%)
Exhibits31: Data Table on End-user – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by End-user
Exhibits33: Data Table on Comparison by End-user
Exhibits34: Chart on Hospital – Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Hospital – Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Hospital – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Hospital – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Clinics – Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Clinics – Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Clinics – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Clinics – Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Others – Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Others – Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Others – Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Others – Year-over-year growth 2022-2027 (%)
Exhibits46: Market opportunity by End-user ($ million)
Exhibits47: Data Table on Market opportunity by End-user ($ million)
Exhibits48: Chart on Product – Market share 2022-2027 (%)
Exhibits49: Data Table on Product – Market share 2022-2027 (%)
Exhibits50: Chart on Comparison by Product
Exhibits51: Data Table on Comparison by Product
Exhibits52: Chart on Non-surgical treatment – Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on Non-surgical treatment – Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on Non-surgical treatment – Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Non-surgical treatment – Year-over-year growth 2022-2027 (%)
Exhibits56: Chart on Surgical treatment – Market size and forecast 2022-2027 ($ million)
Exhibits57: Data Table on Surgical treatment – Market size and forecast 2022-2027 ($ million)
Exhibits58: Chart on Surgical treatment – Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Surgical treatment – Year-over-year growth 2022-2027 (%)
Exhibits60: Market opportunity by Product ($ million)
Exhibits61: Data Table on Market opportunity by Product ($ million)
Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits63: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits65: Chart on Geographic comparison
Exhibits66: Data Table on Geographic comparison
Exhibits67: Chart on North America – Market size and forecast 2022-2027 ($ million)
Exhibits68: Data Table on North America – Market size and forecast 2022-2027 ($ million)
Exhibits69: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits70: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits71: Chart on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on US – Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on US – Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on Canada – Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on Canada – Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on Canada – Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on UK – Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on UK – Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on UK – Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on UK – Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on China – Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on China – Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits103: Market opportunity By Geographical Landscape ($ million)
Exhibits104: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits105: Impact of drivers and challenges in 2022 and 2027
Exhibits106: Overview on Criticality of inputs and Factors of differentiation
Exhibits107: Overview on factors of disruption
Exhibits108: Impact of key risks on business
Exhibits109: Vendors covered
Exhibits110: Matrix on vendor position and classification
Exhibits111: Apotex Inc. – Overview
Exhibits112: Apotex Inc. – Product / Service
Exhibits113: Apotex Inc. – Key offerings
Exhibits114: Aurobindo Pharma Ltd. – Overview
Exhibits115: Aurobindo Pharma Ltd. – Product / Service
Exhibits116: Aurobindo Pharma Ltd. – Key offerings
Exhibits117: Bayer AG – Overview
Exhibits118: Bayer AG – Business segments
Exhibits119: Bayer AG – Key news
Exhibits120: Bayer AG – Key offerings
Exhibits121: Bayer AG – Segment focus
Exhibits122: Dr Reddys Laboratories Ltd. – Overview
Exhibits123: Dr Reddys Laboratories Ltd. – Business segments
Exhibits124: Dr Reddys Laboratories Ltd. – Key offerings
Exhibits125: Dr Reddys Laboratories Ltd. – Segment focus
Exhibits126: Elam Pharma Pvt. Ltd. – Overview
Exhibits127: Elam Pharma Pvt. Ltd. – Product / Service
Exhibits128: Elam Pharma Pvt. Ltd. – Key offerings
Exhibits129: Fresenius SE and Co. KGaA – Overview
Exhibits130: Fresenius SE and Co. KGaA – Business segments
Exhibits131: Fresenius SE and Co. KGaA – Key news
Exhibits132: Fresenius SE and Co. KGaA – Key offerings
Exhibits133: Fresenius SE and Co. KGaA – Segment focus
Exhibits134: Glenmark Pharmaceuticals Ltd. – Overview
Exhibits135: Glenmark Pharmaceuticals Ltd. – Product / Service
Exhibits136: Glenmark Pharmaceuticals Ltd. – Key offerings
Exhibits137: Hikma Pharmaceuticals Plc – Overview
Exhibits138: Hikma Pharmaceuticals Plc – Business segments
Exhibits139: Hikma Pharmaceuticals Plc – Key offerings
Exhibits140: Hikma Pharmaceuticals Plc – Segment focus
Exhibits141: Johnson and Johnson – Overview
Exhibits142: Johnson and Johnson – Business segments
Exhibits143: Johnson and Johnson – Key news
Exhibits144: Johnson and Johnson – Key offerings
Exhibits145: Johnson and Johnson – Segment focus
Exhibits146: Novartis AG – Overview
Exhibits147: Novartis AG – Business segments
Exhibits148: Novartis AG – Key offerings
Exhibits149: Novartis AG – Segment focus
Exhibits150: Omega Laser Systems Ltd. – Overview
Exhibits151: Omega Laser Systems Ltd. – Product / Service
Exhibits152: Omega Laser Systems Ltd. – Key offerings
Exhibits153: Ozone Pharmaceuticals Ltd. – Overview
Exhibits154: Ozone Pharmaceuticals Ltd. – Key offerings
Exhibits155: Pfizer Inc. – Overview
Exhibits156: Pfizer Inc. – Product / Service
Exhibits157: Pfizer Inc. – Key news
Exhibits158: Pfizer Inc. – Key offerings
Exhibits159: Teva Pharmaceutical Industries Ltd. – Overview
Exhibits160: Teva Pharmaceutical Industries Ltd. – Business segments
Exhibits161: Teva Pharmaceutical Industries Ltd. – Key news
Exhibits162: Teva Pharmaceutical Industries Ltd. – Key offerings
Exhibits163: Teva Pharmaceutical Industries Ltd. – Segment focus
Exhibits164: Viatris Inc. – Overview
Exhibits165: Viatris Inc. – Business segments
Exhibits166: Viatris Inc. – Key news
Exhibits167: Viatris Inc. – Key offerings
Exhibits168: Viatris Inc. – Segment focus
Exhibits169: Inclusions checklist
Exhibits170: Exclusions checklist
Exhibits171: Currency conversion rates for US$
Exhibits172: Research methodology
Exhibits173: Validation techniques employed for market sizing
Exhibits174: Information sources
Exhibits175: List of abbreviations



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/



※注目の調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(IRTNTR73640-23 )"坐骨神経痛治療の世界市場2023~2027" (英文:Global Sciatica Treatment Market 2023-2027)はTechnavio社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。